Drug Patent Linkage & Drug Patent Term Extension – Current Situation Around the World (RECORDING)

Jaeyoung IM is a patent attorney and works as IP head at VORONOI, a pharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs. He leads the IP team of VORONOI, particularly, manages the company's global IP portfolio through strategic patent prosecution and litigation, and handles IP related agreements. So far, he worked on a number of open innovation agreement deals including license agreement deals with global pharmaceutical companies. Mr. IM majored in chemical and biological engineering at Seoul National University. He began his IP career at KIM & CHANG, which is a tier 1 law firm in South Korea, as a patent attorney in the chemical/pharmaceutical department. He also worked at JunHe Law firm in Shanghai as a visiting attorney from 2017 to 2018. Mr. IM’s practice focuses on a wide range of intellectual property matters including patent prosecution, litigation, enforcement, and transaction.

Toby Mak is a patent attorney at the Beijing-based IP law firm Tee & Howe. He has substantial experience in both contentious and non-contentious matters, including those relating to prosecution, invalidation, and enforcement. He is one of the authors of "Patent Law in Greater China," published with the EPO. He has a Ph.D. in Chemistry and has served many clients in different technical fields including power tools, semiconductors, adhesives, and video-on-demand. He is also an active member of IPO’s Asian Practice committee.

Corey Salsberg is Vice President and Global Head of IP Affairs for Novartis, a global healthcare company headquartered in Switzerland. He develops and advocates for the company’s policy positions. Prior to joining Novartis, Corey was an IP litigator in private practice.